Skye Bioscience, Inc. (SKYE)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Skye Bioscience, Inc.’s names, not what it holds today.
2 published
1 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jul 31, 2025 | 2025/0243270 | PREDICTION AND TREATMENT OF FAST PROGRESSING RENAL DISEASE | Pharmaceuticals | BIRD ROCK BIO SUB, INC. |
| Jul 24, 2025 | 2025/0236669 | Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor | Pharmaceuticals | BIRD ROCK BIO SUB, INC. |
| Oct 14, 2021 | 2021/0315837 | CANNABINOIDS FOR THE TREATMENT OF GRAM-POSITIVE INFECTIONS INCLUDING ANTIBIOTIC-RESISTANT BACTERIAL STRAINS | Pharmaceuticals | Nemus Bioscience, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.